Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Warnex Inc WNXXF

GREY:WNXXF - Post Discussion

Warnex Inc > Valeant
View:
Post by hotginger on Jan 08, 2014 4:43pm

Valeant

What do we think of Valeant as a possible buyer. They may be able to benefit from the operating tax loss carry forward??

HG

Comment by RTO on Jan 11, 2014 10:30am
Valeant are already a public listed on the NYSE under the symbol VRX. I do see however Clementia Pharma as a possible fit, but that is only my opinion. Should hear something soon.
Comment by hotginger on Jan 12, 2014 4:47pm
Yes, a very good possibility. Allan Mandelzys (ex CEO Thallion) is on their board. HG
Comment by MicroInvestor on Jan 14, 2014 4:20pm
Warnex has no operating business right now so their value is the liquidation value plus an additional amount if acquired by a company requiring the tax loss.  I can't locate their financial statements on Sedar or the company website.  Where are the financial statements to determine the value of their tax losses?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities